Smartphone App for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two smartphone apps to evaluate their effectiveness in helping people quit smoking. KickAsh focuses on teaching relaxation skills, while Breathe2Relax aims to improve mood and increase enjoyable activities. The trial seeks current smokers who have smoked for at least a year, have elevated depressive symptoms now or in the past, and are ready to quit within the next month. Participants must have an Apple device and regularly use apps. As an unphased trial, this study offers a unique opportunity to explore innovative tools to support the journey to quit smoking.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if any medication could compromise your safety or treatment, the Principal Investigator may decide it's necessary.
What prior data suggests that these smartphone mobile applications are safe for smoking cessation?
Research shows that the KickAsh smartphone app is popular with users and may help smokers quit. Previous studies found that users felt better and were more likely to stop smoking. No serious side effects emerged, indicating the app is safe to use.
For the Breathe2Relax app, studies indicate it's a useful tool for managing stress. It provides exercises to help users relax and has been used without any major problems. Overall, both apps appear safe and well-liked by users.12345Why are researchers excited about this trial?
Researchers are excited about these smartphone apps for smoking cessation because they offer unique, personalized approaches to help individuals quit smoking. Unlike traditional methods like nicotine replacement therapy or prescription medications, these apps focus on behavioral changes. The KickAsh app aims to teach relaxation skills over an eight-week period, helping users manage cravings and stress without relying on nicotine. On the other hand, the Breathe2Relax app is designed to boost mood and encourage enjoyable activities, providing a positive reinforcement strategy to aid in quitting smoking. These digital tools provide an innovative, accessible, and potentially empowering way for people to combat smoking addiction.
What evidence suggests that these smartphone mobile applications are effective for smoking cessation?
Research has shown that smartphone apps can help people quit smoking. In this trial, participants will use one of two apps. Some participants will use the KickAsh app, designed to help users relax and potentially lower the urge to smoke. Studies have found that people using such apps are more likely to quit smoking over time. Meanwhile, other participants will use the Breathe2Relax app, which helps improve mood and encourages enjoyable activities, potentially reducing smoking. Although more research is needed, these apps appear promising as tools to support smoking cessation.13467
Who Is on the Research Team?
Jennifer A. Minnix
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for English-speaking MD Anderson patients aged 18-65 who smoke daily, own an iOS device with regular app usage, and are willing to set a quit date within 30 days. They must have smoked for at least a year and either currently have or previously had depressive symptoms. People can't join if they're in another smoking cessation program or have health issues that make the study unsafe for them.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the KickAsh or Breathe2Relax smartphone mobile application designed to help with smoking cessation over 8 weeks
Follow-up
Participants are monitored for changes in activity level, mood, and smoking abstinence
What Are the Treatments Tested in This Trial?
Interventions
- Smartphone Mobile Application
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator